Lyme Disease Science Blog

Confirmation of Borrelia burgdorferi in South America

Borrelia burgdorferi sensu lato (Bb s.l.), the causative agent of Lyme disease, was first reported in 2013 in Ixodes aragaoi ticks in Uruguayan Pampa and has since been found in Argentina and Chile. Now, a new study reports the results of a state surveillance program investigating the presence of Bb in Ixodes spp ticks in Brazilian Pampa.

According to investigators, 2 of the 35 Ixodes spp ticks identified tested positive for Bb s.l. [1] The discovery, however, was not unexpected following reports of borreliosis-like disease in Brazil. “During 2009–2016, Brazil registered 4078 suspected cases of borreliosis-like disease, also known as Baggio-Yoshinari syndrome,” states Dall’Agnol from the Instituto de Pesquisas Veterinárias Desidério Finamor in Eldorado do Sul, Brazil. [1]

“Of those cases, 679 people were positive for Borrelia spp. by Western blotting and enzyme immunoassay tests,” he adds. “Here, we show for the first time evidence of the presence of B. burgdorferi s.l. in its classic vector, Ixodes spp. ticks, in Brazil.” The authors, however, were not able to explain why Bb s.l. was found only in the Ixodes longiscutatus ticks.

The delay in finding Bb s.l. in Ixodes spp. ticks may have been due to the shortcomings of their surveillance programs and surveys. “The lack of reports of Bb s.l. in ticks in Brazil may be due to the absence of a sound surveillance program or surveys focused on Borrelia spp. detection,” Dall’Agnol explains.

“The set of results presented here, in addition to the lack of investigation of suspected human cases of borreliosis, highlights the need for the implementation of public health policies for the diagnosis and prevention of human borreliosis in Brazil.” Furthermore, Dall’Agnol claims additional studies “are needed to fill the gaps in the distribution, pathogenicity, potential vertebrate reservoirs and vectors of the South American haplotypes of Bb s.l.”

Search Blogs

Dr. Daniel Cameron, MD, MPH, is a nationally recognized leader for his expertise in the diagnosis and treatment of Lyme disease and other tick-borne illnesses. For more than 25 years, he has been treating adolescents and adults suffering from Lyme disease.

Introduction

Dr. Daniel Cameron, MD, MPH, is a nationally recognized leader for his expertise in the diagnosis and treatment of Lyme disease and other tick-borne illnesses. For more than 30 years, he has been treating adolescents and adults suffering from Lyme disease.